How personal loss and hope drove Elaine Maynard’s work in clinical trials and patient-centric technologies

Citius Pharma receives FDA approval for immunotherapy targeting rare blood cancer

Halda Therapeutics raises $126M to take 'hold and kill' precision cancer drugs to the clinic

Gilead gains accelerated FDA approval for rare liver disease treatment

FDA lifts hold on BioNTech and MediLink's ADC trial After safety revisions

Breakthrough delivery system could transform Alzheimer’s treatment

First bispecific CAR-T therapy for MS receives green light from FDA to start phase 1

Breaking News: Lecanemab approved in UK but unavailable on NHS

Highlights

array(40) {
  [0]=>
  string(4) "8832"
  ["article_id"]=>
  string(4) "8832"
  [1]=>
  string(52) "Drugmakers Deploy Medical Staff for COVID-19 Efforts"
  ["article_title"]=>
  string(52) "Drugmakers Deploy Medical Staff for COVID-19 Efforts"
  [2]=>
  string(156) "&#nl        Pfizer, Eli Lilly and Merck are allowing their employees who are licensed medical professionals to volunteer in COVID-19 medical efforts.&#nl   "
  ["short_description"]=>
  string(156) "&#nl        Pfizer, Eli Lilly and Merck are allowing their employees who are licensed medical professionals to volunteer in COVID-19 medical efforts.&#nl   "
  [3]=>
  string(159) "&#nl        Pfizer, Eli Lilly and Merck are allowing their employees who are licensed medical professionals to volunteer in COVID-19 medical efforts.&#nl      "
  ["description"]=>
  string(159) "&#nl        Pfizer, Eli Lilly and Merck are allowing their employees who are licensed medical professionals to volunteer in COVID-19 medical efforts.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(92) "https://www.fdanews.com/articles/196521-drugmakers-deploy-medical-staff-for-covid-19-efforts"
  ["blog_url"]=>
  string(92) "https://www.fdanews.com/articles/196521-drugmakers-deploy-medical-staff-for-covid-19-efforts"
  [15]=>
  string(19) "2020-04-04 07:09:17"
  ["add_date"]=>
  string(19) "2020-04-04 07:09:17"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:46"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:46"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Drugmakers Deploy Medical Staff for COVID-19 Efforts

&#nl Pfizer, Eli Lilly and Merck are allowing their employees who are licensed medical professionals to volunteer

array(40) {
  [0]=>
  string(4) "8853"
  ["article_id"]=>
  string(4) "8853"
  [1]=>
  string(46) "SeaSpine Reports Granting of Inducement Awards"
  ["article_title"]=>
  string(46) "SeaSpine Reports Granting of Inducement Awards"
  [2]=>
  string(150) "CARLSBAD, Calif., April  03, 2020  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on su"
  ["short_description"]=>
  string(150) "CARLSBAD, Calif., April  03, 2020  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on su"
  [3]=>
  string(302) "
CARLSBAD, Calif., April  03, 2020  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has issued inducement awards to nine non-executive employees.
"
  ["description"]=>
  string(302) "
CARLSBAD, Calif., April  03, 2020  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has issued inducement awards to nine non-executive employees.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "26"
  ["rss_id"]=>
  string(2) "26"
  [14]=>
  string(117) "http://www.globenewswire.com/news-release/2020/04/03/2011695/0/en/SeaSpine-Reports-Granting-of-Inducement-Awards.html"
  ["blog_url"]=>
  string(117) "http://www.globenewswire.com/news-release/2020/04/03/2011695/0/en/SeaSpine-Reports-Granting-of-Inducement-Awards.html"
  [15]=>
  string(19) "2020-04-04 04:05:00"
  ["add_date"]=>
  string(19) "2020-04-04 04:05:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:41:59"
  ["create_at"]=>
  string(19) "2020-04-12 16:41:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

SeaSpine Reports Granting of Inducement Awards

CARLSBAD, Calif., April 03, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical

array(40) {
  [0]=>
  string(4) "9005"
  ["article_id"]=>
  string(4) "9005"
  [1]=>
  string(64) "UK Aerospace and Automotive Companies to Manufacture Ventilators"
  ["article_title"]=>
  string(64) "UK Aerospace and Automotive Companies to Manufacture Ventilators"
  [2]=>
  string(163) "&#nl        UNITED KINGDOM — A group of businesses from across the UK’s aerospace, automotive and medical sectors have come together to produce medic"
  ["short_description"]=>
  string(163) "&#nl        UNITED KINGDOM — A group of businesses from across the UK’s aerospace, automotive and medical sectors have come together to produce medic"
  [3]=>
  string(237) "&#nl        UNITED KINGDOM — A group of businesses from across the UK’s aerospace, automotive and medical sectors have come together to produce medical ventilators to help Britain’s fight against COVID-19. &#nl      "
  ["description"]=>
  string(237) "&#nl        UNITED KINGDOM — A group of businesses from across the UK’s aerospace, automotive and medical sectors have come together to produce medical ventilators to help Britain’s fight against COVID-19. &#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "99"
  ["rss_id"]=>
  string(2) "99"
  [14]=>
  string(107) "https://www.assemblymag.com/articles/95620-uk-aerospace-and-automotive-companies-to-manufacture-ventilators"
  ["blog_url"]=>
  string(107) "https://www.assemblymag.com/articles/95620-uk-aerospace-and-automotive-companies-to-manufacture-ventilators"
  [15]=>
  string(19) "2020-04-04 01:32:20"
  ["add_date"]=>
  string(19) "2020-04-04 01:32:20"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:50"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

UK Aerospace and Automotive Companies to Manufacture Ventilators

&#nl UNITED KINGDOM — A group of businesses from across the UK’s aerospace, automotive and medical 

array(40) {
  [0]=>
  string(4) "8954"
  ["article_id"]=>
  string(4) "8954"
  [1]=>
  string(69) "Medical device companies respond to UK government's call for help"
  ["article_title"]=>
  string(69) "Medical device companies respond to UK government's call for help"
  [2]=>
  string(155) "Five medical device companies, who are part of the Cambridge Cluster, have responded to the UK government’s call to assist in the rapid development "
  ["short_description"]=>
  string(155) "Five medical device companies, who are part of the Cambridge Cluster, have responded to the UK government’s call to assist in the rapid development "
  [3]=>
  string(220) "Five medical device companies, who are part of the Cambridge Cluster, have responded to the UK government’s call to assist in the rapid development and manufacture of ventilators to meet demand caused by Covid-19."
  ["description"]=>
  string(220) "Five medical device companies, who are part of the Cambridge Cluster, have responded to the UK government’s call to assist in the rapid development and manufacture of ventilators to meet demand caused by Covid-19."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(102) "https://www.medicalplasticsnews.com/news/medical-device-companies-respond-to-uk-government-s-call-for/"
  ["blog_url"]=>
  string(102) "https://www.medicalplasticsnews.com/news/medical-device-companies-respond-to-uk-government-s-call-for/"
  [15]=>
  string(19) "2020-04-03 23:28:14"
  ["add_date"]=>
  string(19) "2020-04-03 23:28:14"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:21"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Medical device companies respond to UK government's call for help

Five medical device companies, who are part of the Cambridge Cluster, have responded to the UK government’s call 

array(40) {
  [0]=>
  string(4) "8802"
  ["article_id"]=>
  string(4) "8802"
  [1]=>
  string(66) "Up to 15% pharmacy staff off work in some chains owing to COVID-19"
  ["article_title"]=>
  string(66) "Up to 15% pharmacy staff off work in some chains owing to COVID-19"
  [2]=>
  string(150) "Small-to-medium sized pharmacy chains are operating with up to 15% of their community pharmacy staff off work as a result of COVID-19, The Association"
  ["short_description"]=>
  string(150) "Small-to-medium sized pharmacy chains are operating with up to 15% of their community pharmacy staff off work as a result of COVID-19, The Association"
  [3]=>
  string(195) "Small-to-medium sized pharmacy chains are operating with up to 15% of their community pharmacy staff off work as a result of COVID-19, The Association of Independent Multiple Pharmacies has said."
  ["description"]=>
  string(195) "Small-to-medium sized pharmacy chains are operating with up to 15% of their community pharmacy staff off work as a result of COVID-19, The Association of Independent Multiple Pharmacies has said."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(144) "https://www.pharmaceutical-journal.com/news-and-analysis/news/up-to-15-pharmacy-staff-off-work-in-some-chains-owing-to-covid-19/20207875.article"
  ["blog_url"]=>
  string(144) "https://www.pharmaceutical-journal.com/news-and-analysis/news/up-to-15-pharmacy-staff-off-work-in-some-chains-owing-to-covid-19/20207875.article"
  [15]=>
  string(19) "2020-04-03 23:12:00"
  ["add_date"]=>
  string(19) "2020-04-03 23:12:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:41"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Up to 15% pharmacy staff off work in some chains owing to COVID-19

Small-to-medium sized pharmacy chains are operating with up to 15% of their community pharmacy staff off work as a resul

array(40) {
  [0]=>
  string(4) "8803"
  ["article_id"]=>
  string(4) "8803"
  [1]=>
  string(53) "COVID-19 updates: 18 March 2020 – 3 April 2020"
  ["article_title"]=>
  string(53) "COVID-19 updates: 18 March 2020 – 3 April 2020"
  [2]=>
  string(109) "All the most important developments in the COVID-19 pandemic for pharmacists and their teams, as they happen."
  ["short_description"]=>
  string(109) "All the most important developments in the COVID-19 pandemic for pharmacists and their teams, as they happen."
  [3]=>
  string(109) "All the most important developments in the COVID-19 pandemic for pharmacists and their teams, as they happen."
  ["description"]=>
  string(109) "All the most important developments in the COVID-19 pandemic for pharmacists and their teams, as they happen."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(127) "https://www.pharmaceutical-journal.com/news-and-analysis/news-blog/covid-19-updates-18-march-2020-3-april-2020/20207894.article"
  ["blog_url"]=>
  string(127) "https://www.pharmaceutical-journal.com/news-and-analysis/news-blog/covid-19-updates-18-march-2020-3-april-2020/20207894.article"
  [15]=>
  string(19) "2020-04-03 22:25:00"
  ["add_date"]=>
  string(19) "2020-04-03 22:25:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:41"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

COVID-19 updates: 18 March 2020 – 3 April 2020

All the most important developments in the COVID-19 pandemic for pharmacists and their teams, as they happen.

array(40) {
  [0]=>
  string(4) "8854"
  ["article_id"]=>
  string(4) "8854"
  [1]=>
  string(139) " Press Release Oncology Venture draws down the first tranche under its Convertible note agreement with Negma Group LTD and Park Partners GB"
  ["article_title"]=>
  string(139) " Press Release Oncology Venture draws down the first tranche under its Convertible note agreement with Negma Group LTD and Park Partners GB"
  [2]=>
  string(165) "Hørsholm, Denmark, April 3rd, 2020 – Oncology Venture A/S (”Oncology Venture”) today announces that it has called upon the first tranche of SEK"
  ["short_description"]=>
  string(165) "Hørsholm, Denmark, April 3rd, 2020 – Oncology Venture A/S (”Oncology Venture”) today announces that it has called upon the first tranche of SEK"
  [3]=>
  string(560) "
Hørsholm, Denmark, April 3rd, 2020 – Oncology Venture A/S (”Oncology Venture”) today announces that it has called upon the first tranche of SEK 10 million in line with the terms from the financing agreement communicated on March 31st, 2020. The transaction is carried out through a private placement of convertible notes. It is the first tranche out of a flexible financing agreement allowing Oncology Venture to request up to a total of SEK 100 million.
"
  ["description"]=>
  string(560) "
Hørsholm, Denmark, April 3rd, 2020 – Oncology Venture A/S (”Oncology Venture”) today announces that it has called upon the first tranche of SEK 10 million in line with the terms from the financing agreement communicated on March 31st, 2020. The transaction is carried out through a private placement of convertible notes. It is the first tranche out of a flexible financing agreement allowing Oncology Venture to request up to a total of SEK 100 million.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "26"
  ["rss_id"]=>
  string(2) "26"
  [14]=>
  string(209) "http://www.globenewswire.com/news-release/2020/04/03/2011451/0/en/Press-Release-Oncology-Venture-draws-down-the-first-tranche-under-its-Convertible-note-agreement-with-Negma-Group-LTD-and-Park-Partners-GB.html"
  ["blog_url"]=>
  string(209) "http://www.globenewswire.com/news-release/2020/04/03/2011451/0/en/Press-Release-Oncology-Venture-draws-down-the-first-tranche-under-its-Convertible-note-agreement-with-Negma-Group-LTD-and-Park-Partners-GB.html"
  [15]=>
  string(19) "2020-04-03 20:16:00"
  ["add_date"]=>
  string(19) "2020-04-03 20:16:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:41:59"
  ["create_at"]=>
  string(19) "2020-04-12 16:41:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Press Release Oncology Venture draws down the first tranche under its Convertible note ag

Hørsholm, Denmark, April 3rd, 2020 – Oncology Venture 

array(40) {
  [0]=>
  string(4) "8833"
  ["article_id"]=>
  string(4) "8833"
  [1]=>
  string(65) "Chinese Trial Suggests Hydroxychloroquine Helps COVID-19 Patients"
  ["article_title"]=>
  string(65) "Chinese Trial Suggests Hydroxychloroquine Helps COVID-19 Patients"
  [2]=>
  string(153) "&#nl        The anti-malaria drug hydroxychloroquine was effective in treating COVID-19 patients in China, according to early data from a small clinical "
  ["short_description"]=>
  string(153) "&#nl        The anti-malaria drug hydroxychloroquine was effective in treating COVID-19 patients in China, according to early data from a small clinical "
  [3]=>
  string(169) "&#nl        The anti-malaria drug hydroxychloroquine was effective in treating COVID-19 patients in China, according to early data from a small clinical trial.&#nl      "
  ["description"]=>
  string(169) "&#nl        The anti-malaria drug hydroxychloroquine was effective in treating COVID-19 patients in China, according to early data from a small clinical trial.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(105) "https://www.fdanews.com/articles/196507-chinese-trial-suggests-hydroxychloroquine-helps-covid-19-patients"
  ["blog_url"]=>
  string(105) "https://www.fdanews.com/articles/196507-chinese-trial-suggests-hydroxychloroquine-helps-covid-19-patients"
  [15]=>
  string(19) "2020-04-03 07:50:10"
  ["add_date"]=>
  string(19) "2020-04-03 07:50:10"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:46"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:46"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Chinese Trial Suggests Hydroxychloroquine Helps COVID-19 Patients

&#nl The anti-malaria drug hydroxychloroquine was effective in treating COVID-19 patients in China, according to 

array(40) {
  [0]=>
  string(4) "8804"
  ["article_id"]=>
  string(4) "8804"
  [1]=>
  string(77) "Asthma inhaler stocks low after COVID-19 linked demand spike, government says"
  ["article_title"]=>
  string(77) "Asthma inhaler stocks low after COVID-19 linked demand spike, government says"
  [2]=>
  string(152) "Pharmacies are experiencing difficulties sourcing some commonly used asthma inhalers, following a surge in demand caused by the COVID-19 pandemic, Th"
  ["short_description"]=>
  string(152) "Pharmacies are experiencing difficulties sourcing some commonly used asthma inhalers, following a surge in demand caused by the COVID-19 pandemic, Th"
  [3]=>
  string(188) "Pharmacies are experiencing difficulties sourcing some commonly used asthma inhalers, following a surge in demand caused by the COVID-19 pandemic, The Pharmaceutical Journal can reveal."
  ["description"]=>
  string(188) "Pharmacies are experiencing difficulties sourcing some commonly used asthma inhalers, following a surge in demand caused by the COVID-19 pandemic, The Pharmaceutical Journal can reveal."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(155) "https://www.pharmaceutical-journal.com/news-and-analysis/news/asthma-inhaler-stocks-low-after-covid-19-linked-demand-spike-government-says/20207873.article"
  ["blog_url"]=>
  string(155) "https://www.pharmaceutical-journal.com/news-and-analysis/news/asthma-inhaler-stocks-low-after-covid-19-linked-demand-spike-government-says/20207873.article"
  [15]=>
  string(19) "2020-04-03 00:56:00"
  ["add_date"]=>
  string(19) "2020-04-03 00:56:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:41"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Asthma inhaler stocks low after COVID-19 linked demand spike, government says

Pharmacies are experiencing difficulties sourcing some commonly used asthma inhalers, following a surge in demand caused

array(40) {
  [0]=>
  string(4) "8866"
  ["article_id"]=>
  string(4) "8866"
  [1]=>
  string(117) "DR. SCHOLL’S DONATES $1.3 MILLION IN PRODUCTS TO SUPPORT HEALTH CARE WORKERS ON THE FRONT LINES OF COVID-19"
  ["article_title"]=>
  string(117) "DR. SCHOLL’S DONATES $1.3 MILLION IN PRODUCTS TO SUPPORT HEALTH CARE WORKERS ON THE FRONT LINES OF COVID-19"
  [2]=>
  string(92) "Hospitals Can Submit Requests To Receive Dr. Scholl’s Insole Donations For Caregivers"
  ["short_description"]=>
  string(92) "Hospitals Can Submit Requests To Receive Dr. Scholl’s Insole Donations For Caregivers"
  [3]=>
  string(169) "
Hospitals Can Submit Requests To Receive Dr. Scholl’s Insole Donations For Caregivers
"
  ["description"]=>
  string(169) "
Hospitals Can Submit Requests To Receive Dr. Scholl’s Insole Donations For Caregivers
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "27"
  ["rss_id"]=>
  string(2) "27"
  [14]=>
  string(176) "http://www.globenewswire.com/news-release/2020/04/02/2010993/0/en/DR-SCHOLL-S-DONATES-1-3-MILLION-IN-PRODUCTS-TO-SUPPORT-HEALTH-CARE-WORKERS-ON-THE-FRONT-LINES-OF-COVID-19.html"
  ["blog_url"]=>
  string(176) "http://www.globenewswire.com/news-release/2020/04/02/2010993/0/en/DR-SCHOLL-S-DONATES-1-3-MILLION-IN-PRODUCTS-TO-SUPPORT-HEALTH-CARE-WORKERS-ON-THE-FRONT-LINES-OF-COVID-19.html"
  [15]=>
  string(19) "2020-04-03 00:26:00"
  ["add_date"]=>
  string(19) "2020-04-03 00:26:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:04"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:04"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

DR. SCHOLL’S DONATES $1.3 MILLION IN PRODUCTS TO SUPPORT HEALTH CARE WORKERS ON

Hospitals Can Submit Requests To Receive Dr. Scholl’s Insole Donati

array(40) {
  [0]=>
  string(4) "8975"
  ["article_id"]=>
  string(4) "8975"
  [1]=>
  string(72) "Advarra presents free clinical research resources during COVID-19 crisis"
  ["article_title"]=>
  string(72) "Advarra presents free clinical research resources during COVID-19 crisis"
  [2]=>
  string(139) "The research consulting and solutions provider will offer complimentary transfer of IRB oversight, access to eRegulatory software and more."
  ["short_description"]=>
  string(139) "The research consulting and solutions provider will offer complimentary transfer of IRB oversight, access to eRegulatory software and more."
  [3]=>
  string(139) "The research consulting and solutions provider will offer complimentary transfer of IRB oversight, access to eRegulatory software and more."
  ["description"]=>
  string(139) "The research consulting and solutions provider will offer complimentary transfer of IRB oversight, access to eRegulatory software and more."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(157) "https://www.outsourcing-pharma.com/Article/2020/04/02/Free-clinical-research-resources-in-COVID-19-crisis?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(157) "https://www.outsourcing-pharma.com/Article/2020/04/02/Free-clinical-research-resources-in-COVID-19-crisis?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-04-02 23:50:00"
  ["add_date"]=>
  string(19) "2020-04-02 23:50:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:24"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Advarra presents free clinical research resources during COVID-19 crisis

The research consulting and solutions provider will offer complimentary transfer of IRB oversight, access to eRegulatory

array(40) {
  [0]=>
  string(4) "9010"
  ["article_id"]=>
  string(4) "9010"
  [1]=>
  string(76) "Arch Venture raises $1.4bn fund to spur ‘healthcare revolution’"
  ["article_title"]=>
  string(76) "Arch Venture raises $1.4bn fund to spur ‘healthcare revolution’"
  [2]=>
  string(116) "Arch Venture announces that it raised the sum across two funds, with the capital earmarked for early stage biotechs."
  ["short_description"]=>
  string(116) "Arch Venture announces that it raised the sum across two funds, with the capital earmarked for early stage biotechs."
  [3]=>
  string(116) "Arch Venture announces that it raised the sum across two funds, with the capital earmarked for early stage biotechs."
  ["description"]=>
  string(116) "Arch Venture announces that it raised the sum across two funds, with the capital earmarked for early stage biotechs."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(145) "https://www.biopharma-reporter.com/Article/2020/04/02/Arch-Venture-raises-billion-dollar-fund?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(145) "https://www.biopharma-reporter.com/Article/2020/04/02/Arch-Venture-raises-billion-dollar-fund?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-04-02 22:37:00"
  ["add_date"]=>
  string(19) "2020-04-02 22:37:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:55"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:55"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Arch Venture raises $1.4bn fund to spur ‘healthcare revolution’

Arch Venture announces that it raised the sum across two funds, with the capital earmarked for early stage biotechs.